Estimated glomerular filtration rate (eGFR) (using Cockcroft & Gault equation) >  mL/min, within  days of registration
estimated creatinine clearance (CrCl, by Cockcroft-Gault formula) or estimated glomerular filtration rate (eGFR) ?  mL/min/. m
Subject has any of following laboratory abnormalities: WBC < /uL; ANC < /uL; Hemoglobin <  g/dL; Estimated glomerular filtration rate <  mL/min/. m; ALT >  x ULN ; Bilirubin > . x ULN
Estimated glomerular filtration rate (EGFR) >=  ml/min
Serum creatinine ?. mg/dL or eGFR (estimated Glomerular Filtration Rate) <  mL/min.
Estimated glomerular filtration rate (eGFR) of >  mls/min using Cockcroft and Gault formula
Creatinine =< . X ULN and estimated glomerular filtration rate (GFR) (eGFR) >=  ml/min
Glomerular filtration rate (either estimated or calculated from -hour urine collection) ?  mL/min
Estimated glomerular filtration rate (eGFR) >=  mL/min/.m^ per current institutional calculation formula (within  days of study registration)
Estimated glomerular filtration rate (eGFR) >=  mL/min/. m^ for participants with creatinine levels above institutional normal OR
Patients will not be eligible if they present with moderate to severe decrease in creatinine clearance (estimated glomerular filtration rate [eGFR] <  mL/min/.m)
Estimated glomerular filtration rate (eGFR) >  mL/min/. m^
Creatinine < . mg/dl OR estimated glomerular filtration rate (eGFR) (creatinine clearance) >=  mL/min/. m^
Estimated glomerular filtration rate (eGFR) >=  mL/min/.m^ per current institutional calculation formula
Patients with estimated glomerular filtration rate (eGFR) <  mL/min/. m^
Estimated glomerular filtration rate (eGFR) >=  mL/min/. m^
Severe renal dysfunction (estimated glomerular filtration rate at the Screening visit; calculated by the central laboratory) < mL/min/. m^ or on chronic dialysis
Estimated glomerular filtration rate (eGFR) of at least  ml/min; the Cockcroft Gault formula will be utilized to determine eGFR when blood urea nitrogen (BUN) and creatinine testing are performed at baseline. The combination of eGFR serum creatinine and BUN will be used to evaluate patient's renal function for safety assurance.
Estimated glomerular filtration rate (eGFR) of at least ml/min using the Cockcroft Gault formula will be determined at base line when testing of BUN and creatinine is performed. The combination of eGFR serum creatinine and BUN will be used to evaluate renal function and assure the safety of this patient function.
Within  days prior to registration: Serum creatinine < . X institutional ULN mg/dL OR estimated glomerular filtration rate (eGFR) >=  mL/min
Estimated glomerular filtration rate (eGFR) of at least  mL/min
Creatinine =< . X institutional upper limit of normal or estimated glomerular filtration rate <  mL/min/. m^
Either serum creatinine ? . x ULN or estimated glomerular filtration rate ?  mL/min/. m^
Estimated glomerular filtration rate (eGFR) >  mL per . m*
Screening laboratory analyses shows any of the following abnormal laboratory results: Estimated Glomerular filtration (eGFR) rate <  mL/min
Estimated glomerular filtration rate (GFR) (eGFR) >=  ml/min
Serum creatinine ?. mg/dL or estimated glomerular filtration rate (eGFR) ? mL/min/. m
Renal impairment defined as estimated glomerular filtration rate (EGFR) < 
Estimated glomerular filtration rate (eGFR) greater than or equal to  ml/min/. m^
Estimated Glomerular Filtration Rate (eGFR) ?  mL/min/. m
Renal function estimated glomerular filtration rate (eGFR) >  mL/min via calculated creatinine clearance
Estimated glomerular filtration rate (eGFR) >=  ml/min/.m^ using the CKD-EPI equation
Creatinine clearance >=  mL/min/. m^ (calculated by estimated glomerular filtration rate [eGFR] from EPIC)
Estimated glomerular filtration rate (eGFR) of at least  mL/min
Patients with >= grade  chronic kidney disease at enrollment (estimated glomerular filtration rate [eGFR] or creatinine clearance [CrCl] <  ml/min/.m^)
All patients must be able to undergo MRI with and without contrast with a glomerular filtration rate (eGFR) greater than or equal to  mg/min/. m^
Patients will have an estimated glomerular filtration rate (eGFR) <  ml/min/. m^
Estimated glomerular filtration rate ? mL/minute
Adequate renal function, defined as serum creatinine ?. times ULN and creatinine clearance > mL/min or estimated glomerular filtration rate (eGFR) > mL/min/. m^
Cisplatin ineligibility based on one or more of the following criteria:\r\n* Estimated glomerular filtration rate (eGFR) - ml/min/.^\r\n* >= Grade  sensory neuropathy\r\n* >= Grade  hearing loss
Estimated glomerular filtration rate (eGFR) <  within  weeks prior to registration
Heart: presence of mean left ventricular wall thickness on echocardiogram greater than  mm in the absence of hypertension or valvular heart disease, or unexplained low voltage (< . mV) on ECG, or NT-proBNP >  ng/L in the absence of impaired renal function [estimated glomerular filtration rate (eGFR) <  mL/min]
Estimated creatinine clearance (CrCl) or estimated glomerular filtration rate (eGFR) ?  mL/min/. m
Calculated creatinine clearance (estimated glomerular filtration rate [eGFR]) >  ml/min
Estimated Glomerular Filtration Rate < mL/min.
estimated glomerular filtration rate >  mL/min
Estimated glomerular filtration rate (eGFR) of >  ml/min as calculated by the Cockcroft-Gault Method
Unless felt due to underlying disease and approved by the overall principal investigator (PI): Creatinine < . mg/dl, and estimated glomerular filtration rate (eGFR) >=  mL/min
Estimated glomerular filtration rate (eGFR) <  within  weeks prior to registration
Estimated glomerular filtration rate (eGFR) >=  mL/min/.m^, as evidenced in laboratory values =<  months old
Contraindication to contrast CMR including estimated glomerular filtration rate (eGFR) <  mls/min/. m^
Estimated glomerular filtration rate (eGFR) >=  mL/min
Have significant renal disease or dysfunction defined as estimated glomerular filtration rate (eGFR) < 
Patient must have adequate bone marrow, coagulation, renal, and hepatic function; estimated glomerular filtration rate (eGFR) calculation >=  mL/min/. m^ (within  days of screening CT submission)
Severe renal insufficiency, estimated glomerular filtration rate (EGFR) < 
Adequate renal function to tolerate intravenous gadolinium contrast injection (estimated glomerular filtration rate >=  mL/min/. m^ prior to initial DCE-MRI and estimated glomerular filtration rate >=  mL/min/. m^ for subsequent DCE-MRI scans)
Contraindications to receiving intravenous gadolinium contrast injection including prior allergic reaction and/or chronic renal insufficiency (estimated glomerular filtration rate <  mL/min/. m^ prior to initial DCE-MRI and estimated glomerular filtration rate <  mL/min/. m^ for subsequent DCE-MRI scans)
Subject has impaired renal function (estimated glomerular filtration rate [eGFR]<  mL/min)
Renal dysfunction with estimated glomerular filtration rate (eGFR) <  mL/min/. m^
Abnormal renal function with estimated glomerular filtration rate (eGFR) less than  mL/min/m^ based on creatinine obtained within last  days
Severe renal function impairment (estimated glomerular filtration rate [eGFR] <  mL/min/. m^) would make the patient inappropriate for enrollment due to the increased risk of nephrogenic systemic fibrosis (NSF) with higher dose of IV gadolinium-based contrast agents (GBCA) administration
Subjects with estimated glomerular filtration rate (eGFR) =<  mL/min/. m^ will not participate in the gadolinium (Gd) contrast-enhanced MRI
Patients with estimated glomerular filtration rate (eGFR) <  are not eligible
Patients with renal function (estimated glomerular filtration rate [eGFR] >= )
Late stage renal failure with estimated glomerular filtration rate (eGFR) of less than  mL/min/. m^ based on patient's serum creatinine; (past  months timeframe will be used to calculate the eGFR)
Estimated glomerular filtration rate (eGFR) <  mL/min/.m^
Patients must have an estimated glomerular filtration rate of >=  mL/min/.m^ within six weeks of the MRI to be included in the study
Subjects with an estimated glomerular filtration rate of <  mL/min/.m^ within six weeks of the MRI
Acute or chronic severe renal insufficiency (estimated glomerular filtration rate <  mL/min/.m^)
Patient with significant renal insufficiency, i.e. an estimated glomerular filtration rate (eGRF) less than  mL/min/.m^
Patient must not have an estimated glomerular filtration rate (eGFR) <  mL/min/. m^
Estimated glomerular filtration rate (eGFR) <  mL/min/. m^
Impaired renal function (chronic kidney disease [CKD]  or : estimated glomerular filtration rate [eGFR] <  mLs/min), which is a contraindication to gadolinium containing contrast
Estimated glomerular filtration rate (eGFR) <  mL/min
Estimated glomerular filtration rate <  mL/min
Subject presenting with acute or chronic Grade III (at least) renal insufficiency, defined as an estimated Glomerular Filtration Rate (eGFR) < mL/min/.m based on two eGFR assessments, one within  days before the first study MRI and on the day of the MRI (if any of the eGFR result is < mL/min/.m, the subject is not eligible).
Contraindication to MRI (e.g. claustrophobia, pacemaker, estimated glomerular filtration rate ? mls/min)
Serum creatinine within  weeks prior to Eovist MRI =< . mg/dl and estimated glomerular filtration rate (eGFR) must be >  ml/min/. m^
Estimated glomerular filtration rate (eGFR) >= GFR  mL/min/. m^
Estimated glomerular filtration rate (eGFR) >  mL/min/. m^ or estimated creatinine clearance (eCrCL) >  mL/min
Have an estimated glomerular filtration rate (eGFR) (using the Cockcroft-Gault equation) of more than  mL/min